Cargando…
Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis
OBJECTIVE: The purpose of this study is to determine the efficacy and safety of lenvatinib as second-line therapy in Chinese patients with unresectable hepatocellular carcinoma (HCC). METHODS: We performed a retrospective analysis of Chinese patients with unresectable HCC who received second-line tr...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723230/ https://www.ncbi.nlm.nih.gov/pubmed/36483048 http://dx.doi.org/10.3389/fonc.2022.1003426 |